Aslan Pharmaceuticals: Case Study of a Start-up in Singapore
Add bookmark
Aslan Pharmaceuticals: Case Study of a Start-up in Singapore
Add bookmarkMost big pharma are now setting up operations in Asia, with China predicted to be the biggest market in pharmaceuticals by 2025. Mark McHale, Chief Scientific Officer at Aslan Pharmaceuticals discusses the set up of the pharma organisation in Singapore over two years ago, looking at the advantages and indeed challenges of operating in the East and the opportunities that lie ahead certainly from 2020 on.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
